期刊名称：NEUROPSYCHIATRIC DISEASE AND TREATMENT ISSN： 1178-2021 出版频率： Continuous publication 出版社： DOVE MEDICAL PRESS LTD, PO BOX 300-008, ALBANY, NEW ZEALAND, AUCKLAND, 0752   出版社网址： http://www.dovepress.com/ 期刊网址： http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journal 影响因子： 2.57 主题范畴： CLINICAL NEUROLOGY;    PSYCHIATRY 变更情况： 期刊简介(About the journal)    投稿须知(Instructions to Authors)    编辑部信息(Editorial Board)    About the journal Neuropsychiatric Disease and Treatment ISSN: 1178-2021 1176-6328 (Print) - went to online only in 2008 An international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders. Journal Impact Factor: 2.154 This journal is a member of and subscribes to the principles of the Committee on Publication Ethics (COPE). Indexed online: PubMed and PubMed Central (Neuropsychiatr Dis Treat) Science Citation Expanded (also known as SciSearch®) Journal Citation Reports/Science Edition The American Psychological Association's 'PsycINFO' database Embase, Scopus and the Elsevier Bibliographic databases Index Copernicus ICAAP Directory of Open Access Journals (DOAJ) OAIster: The Open Access Initiative USA/Canada UK Rest-of-World US$2200.00 £1395.00 €1595.00 Aims and Scope Neuropsychiatric Disease and Treatment is an international, peer-reviewed journal of clinical therapeutics and pharmacology focusing on concise rapid reporting of clinical or pre-clinical studies on a range of neuropsychiatric and neurological disorders.   Instructions to Authors Preparation of Manuscript Include: Forename(s) and surnames of authors (see Authorship section below) Author affiliations: department, institution, city, state, country Abstract 300 words 3–6 keywords Running header (shortened title) Corresponding author: name, physical address, phone, fax, email Reference list Double-spacing 3-cm margins Page numbers Clear concise language American spelling Ensure tables and figures are cited  The preferred electronic format for text is Microsoft Word Manuscripts will be accepted in LaTeX as long as the native LaTeX and a PDF is also supplied Use International Systems of Units (SI) symbols and recognized abbreviations for units of measurement Do not punctuate abbreviations eg, et al, ie Spell out acronyms in the first instance in the abstract and paper Word counts are not specified. In general, shorter items range from 1000 to 3000 words and reviews from 3000 to 7,500 Generic drug names are used in text, tables, and figures Suppliers of drugs, equipment, and other brand-name material are credited in parentheses (company, name, city, state, country) If molecular sequences are used, provide a statement that the data have been deposited in a publicly accessible database, eg, GenBank, and indicate the database accession number. While the editors fully understand the extra challenges posed to authors whose native language is not English, we must ask that all manuscripts be reviewed and edited by a native speaker of English with expertise in that area prior to submission. Authorship Authorship credit should be based on: 1) Substantial contributions to conception and design, acquisition of data, or analysis and interpretation of data; 2) Drafting the article or revising it critically for important intellectual content;  3) Final approval of the version to be published; and 4) Agreement to be accountable for all aspects of the work in ensuring that questions related to the accuracy or integrity of any part of the work are appropriately investigated and resolved. Authors should meet conditions 1, 2, 3, and 4. When a large, multicenter group has conducted the work, the group should identify the individuals who accept direct responsibility for the manuscript (3). These individuals should fully meet the criteria for authorship/contributorship defined above, and editors will ask these individuals to complete journal-specific author and conflict-of-interest disclosure forms. When submitting a manuscript authored by a group, the corresponding author should clearly indicate the preferred citation and identify all individual authors as well as the group name. Journals generally list other members of the group in the Acknowledgments. The NLM indexes the group name and the names of individuals the group has identified as being directly responsible for the manuscript; it also lists the names of collaborators if they are listed in Acknowledgments. Acquisition of funding, collection of data, or general supervision of the research group alone does not constitute authorship. All persons designated as authors should qualify for authorship, and all those who qualify should be listed. Each author should have participated sufficiently in the work to take public responsibility for appropriate portions of the content. Increasingly, authorship of multicenter trials is attributed to a group. All members of the group who are named as authors should fully meet the above criteria for authorship/contributorship. The group should jointly make decisions about contributors/authors before submitting the manuscript for publication. The corresponding author/guarantor should be prepared to explain the presence and order of these individuals. It is not the role of editors to make authorship/contributorship decisions or to arbitrate conflicts related to authorship. Contributors Listed in Acknowledgments All contributors who do not meet the criteria for authorship should be listed in an acknowledgments section. Examples of those who might be acknowledged include a person who provided purely technical help, writing assistance, or a department chairperson who provided only general support. Authors should declare whether they had assistance with study design, data collection, data analysis, or manuscript preparation. If such assistance was available, the authors should disclose the identity of the individuals who provided this assistance and the entity that supported it in the published article. Financial and material support should also be acknowledged. Groups of persons who have contributed materially to the paper but whose contributions do not justify authorship may be listed under such headings as “clinical investigators” or “participating investigators,” and their function or contribution should be described—for example, “served as scientific advisors,” “critically reviewed the study proposal,” “collected data,” or “provided and cared for study patients.” Because readers may infer their endorsement of the data and conclusions, these persons must give written permission to be acknowledged. Please note: the Authorship and “Contributors Listed in Acknowledgments” sections are reprinted from the ICMJE Uniform Requirements for Manuscripts Submitted to Biomedical Journals. Dove Medical Press  prepared this reprint. The ICMJE has not endorsed nor approved the contents of this reprint. The official version of the Uniform Requirements for Manuscripts Submitted to Biomedical Journals is located at http://www.icmje.org/. Users should cite this official version when citing the document. Related Authors Where authors of a paper are related this should be disclosed at the time of submission. Please provide details of the family relationship between such authors. Figures and Tables Submit as separate files and also as one combined file Submit figures as JPG files Number consecutively Provide a descriptive heading/legend Place abbreviations immediately below the table Use superscript a, b, c… as identifiers Supply Line Art 900 dpi, Combination (Line Art + Halftone) 900 dpi, Halftone 300 dpi Graphics downloaded from Web pages are NOT acceptable Submit multi-panel figures, ie with parts labeled a,b,c,d, as one file Supplementary Data Any supplementary data should be kept to 6 typeset pages or 2,400 words. If you have any more than this you should provide a link to the supplementary data on an external website, your institute’s website for example, and/or Dove Medical Press may be able to upload the raw supplementary data to the http://www.dovepress.com/ website and provide a link in your paper. We welcome video files either as supplementary data or as part of the actual manuscript to show operations, procedures, etc.   Letter to the Editor Manuscripts submitted as a Letter to the Editor: Should relate to a paper previously published in a Dove Medical Press journal, or address an issue of wider concern within the scope of the journal; Have a word count of no more than 3,600 words; May contain figures and tables (see specifications for these above); Have references formatted in the Dove Medical Press style. Submission of Manuscript All manuscripts should be submitted via our website.   By doing so you agree to the terms and conditions of submission Keep a backup and hard copies of the material submitted Pre-submissions Authors are welcome to send an abstract or draft manuscript to obtain a view from the Editor about the suitability of their paper. Please email here and include which journal you are interested in submitting your manuscript to. Our Editors will do a quick review (not peer review) of your paper and advise if they believe it is appropriate for submission to their journal. This will be based on subject matter vs the aims and scope of the journal. It will not be a full review of your manuscript. Reference Style See Reference Style Guidelines   Proofs You will receive the typeset page proofs for approval Check amendments made by the editor have not rendered the material inaccurate Check you have answered all the editor’s queries Ensure your corrections are minimal and absolutely necessary Mark the adjustments clearly in the text and margins, and keep a copy of what you send to the editor Notify the editorial office of all corrections within 72 hours of your receipt of the material Ensure all authors sign and return the Author Approval and final page of Publication Agreement   All Dove journals are members of and subscribe to the principles of the Committee on Publication Ethics (COPE). We also support the international standards for editors and authors that were developed at the 2nd World Conference on Research Integrity in Singapore in 2010. Editorial Board Dr Pinder Editor in Chief Dr Pinder Editor-in-Chief:  Dr Roger M. Pinder, PhD, DSc. Dr. Pinder is an independent pharma consultant based in the city of York in the UK. He advises and consults worldwide to several pharmaceutical and venture capital organizations. He is Founding Editor of Neuropsychiatric Disease and Treatment and of the International Journal of Wine Research. He has served as President and Secretary of the International Society for Affective Disorders (ISAD), and as Treasurer and Councillor of the International College of Neuropsychopharmacology (CINP). Educated in the UK and the USA at the universities of Hull and Virginia, Dr. Pinder holds doctoral degrees in medicinal chemistry (Ph.D.) and neuropsychopharmacology (D.Sc.). He is a fellow of the British Pharmacological Society, the British Association for Psychopharmacology, the European (ECNP) and the International Colleges of Neuropsychopharmacology (CINP), and of ISAD, and serves on the Editorial Board of Medicinal Chemistry Research. His professional research interests include cardiovascular and CNS pharmacology and therapeutics, with a special emphasis on depressive disorders, anti-depressants and the health benefits of wine. He is a regular speaker and chair at international congresses, and has published 5 books and more than 250 review and research articles. After a long career in R&D and medical affairs management in the international pharmaceutical industry, Dr.Pinder is now a board member of a number of start-up pharmaceutical companies. Professor Tang Associate Editor in Chief Professor Tang Associate Editor - China: Professor Wai Kwong Tang Professor WK Tang was appointed to Professor in the Department of Psychiatry, the Chinese University of Hong Kong in 2011. Professor Tang completed his medical training at the Chinese University of Hong Kong, he then joined the Chinese University of Hong Kong as an academic staff in 1999. His main research area is Neuropsychiatry in Stroke. Professor Tang has published over 100 papers in renowned journals, and has also contributed to the peer review of 40 journals. He has secured over 20 major competitive research grants. He has served the editorial boards of five scientific journals. He was also a recipient of the Young Researcher Award in 2007, awarded by the Chinese University of Hong Kong.  Honorary Editorial Board 59 Members Professor Adeli United States Hojjat Adeli, Abba G Lichtenstein Professor, The Ohio State University, Columbus, OH, USA Professor Antonini Italy Angelo Antonini, Professor, Parkinson Institute, Milan, Italy Dr Arango Spain Celso Arango, Departmento de Psiquiatría, Hospital Gregorio Marañón, Madrid, Spain Dr Barlinn Germany Kristian Barlinn, Department of Neurology, University Hospital Carl Gustav Carus, Dresden, Germany Professor Boer Netherlands Johan A Den Boer, Professor, University Hospital, Groningen, Netherlands Dr Briley France Mike Briley, NeuroBiz Consulting and Communications, Castres, France Dr Bullock United Kingdom Roger Bullock, Principal Investigator, Kingshill Research Centre, Swindon, UK Professor Calabrese United States Joseph R Calabrese, Professor of Psychiatry, Case Western Reserve University, Cleveland, USA Professor Cassano Italy Giovanni Cassano, Professor and Director, University of Pisa, Italy Dr Chaudhuri United Kingdom K Ray Chaudhuri, Consulting Neurologist, University Hospital, Lewisham; Kings College Hospital, London, UK Professor Chien Hong Kong Wai Tong Chien, Professor and Associate Head (Research), School of Nursing, Faculty of Health and Social Sciences, The Hong Kong Polytechnic University, Hong Kong SAR Professor Cummings United States Jeffrey Cummings, Professor of Neurology and Psychiatry, David Geffen School of Medicine at UCLA, Los Angeles, USA Professor David United Kingdom Anthony David, Professor of Cognitive Neuropsychiatry, Kings College, London, UK Dr Finucane New Zealand Greg Finucane, Neuropsychiatrist, Auckland Hospital, Auckland, New Zealand Professor Frazer United States Alan Frazer, Professor, University of Texas Health Science Centre, San Antonio, USA Professor Gaviria United States Moises Gaviria, Professor of Psychiatry, Director of the Center for Neurobehavioral Services, The McGrath Clinic, University of Illinois at Chicago, USA Professor Harvey South Africa Brian H Harvey, Professor, Division of Pharmacology, School of Pharmacy, North West University, Potchefstroom, South Africa Dr Isaac United Kingdom Mike Isaac, Consultant and Hon Senior Lecturer in Psychiatry, South London & Maudsley NHS FT and University of London, UK Professor Iznak Russia Andrey Iznak, Professor, Mental Health Research Centre, Moscow, Russia Professor Kane United States John Kane, Professor of Psychiatry, Albert Einstein College of Medicine, New York, USA Professor Kasper Austria Siegfried F Kasper, Professor, Medical University of Vienna, Vienna, Austria Professor Kennedy United States John S Kennedy, Professor of Clinical Psychiatry and Medicine, Director Geriatric Psychiatry, Indiana University, Indianapolis, USA Professor Kennedy Canada Sidney H Kennedy, Professor and Psychiatrist-in-Chief, University Health Network, Toronto, Canada Dr Kobeissy United States Firas Kobeissy, Asst Rsrch Prof, Assoc Scientific Dir of Psychoproteomics & Nanotechnology Rsrch Ctr, Dept of Psychiatry, The Evelyn F & William L McKnight Brain Institute, University of Florida, Gainesville, FL, USA Professor Krausz Canada Michael Krausz, Professor, Department of Psychiatry, The University of British Columbia, Vancouver, BC, Canada Dr Krishnamoorthy India Ennapadam Krishnamoorthy, Director, TS Srinivasan Centre for Clinical Neurosciences, Chennai, India; Honorary Professor, Faculty of Medicine, University of Madras, Madras, India Professor Kutcher Canada Stanley Kutcher, Professor, Dalhousie University, Halifax, Canada Professor Leszek Poland Jerzy Leszek , Professor, Wroclaw Medical University Psychiatric Clinic, Wroclaw, Poland Professor Lieberman United States Jeffrey A Lieberman, Professor, UNC Neurosciences Hospital, Chapel Hill, USA Dr Markowitz United States John S Markowitz, Professor, Department of Pharmacotherapy and Translational Research, University of Florida College of Pharmacy, FL, USA Professor Martin United States Peter R Martin, Professor of Psychiatry and Pharmacology, Director, Division of Addiction Psychiatry, Vanderbilt University School of Medicine, Nashville, TN, USA Professor Mendlewicz Belgium Julien Mendlewicz, Professor, Free University of Brussels, Brussels, Belgium Professor Mitsui Japan Shinichi Mitsui, Professor, Department of Rehabilitation Sciences, Gunma University Graduate School of Health Sciences, Gunma, Japan Professor Moeller Germany Hans-Juergen Moller, Professor of Psychiatry, University of Munich, Germany Professor Morita Japan Yoshio Morita, Professor, Department of Neuropsychiatry, Hyogo College of Medicine, Hyogo, Japan Professor Nemeroff United States Charles B Nemeroff, Professor, Emory University School of Medicine, Atlanta, USA Dr Oscar-Berman United States Marlene Oscar Berman, Professor of Psychiatry, Neurology, Anatomy and Neurobiology, Director, Behavioral Neuroscience Ph.D. Program, Boston University School of Medicine, Boston, Massachusetts, USA Dr Pavlovic Germany Zoran M Pavlovic, Director of Scientific Affairs and Clinical Assessments Worldwide Clinical Trials Professor Paykel United Kingdom Eugene S Paykel, Professor Emeritus, University of Cambridge, Cambridge, UK Professor Perry United States George Perry, Dean and Professor, College of Sciences, The University of Texas at San Antonio, San Antonio, USA Professor Potkin United States Steven Potkin, Professor, University of California, Irvine, USA Professor Rimon Finland Ranan Rimon, Professor of Psychiatry, Helsinki University Central Hospital, Helsinki, Finland Professor Rosenberg Denmark Raben Rosenberg, Professor of Biological Psychiatry, Arhus University Hospital, Arhus, Denmark Prof. Dr. Sachdev Australia Perminder Sachdev, Professor of Neuropsychiatry, University of New South Wales, Sydney, Australia Professor Sartorius United Kingdom Norman Sartorius, Honorary Professor of the University of London, London, UK Professor Sato Japan Mitsumoto Sato, Professor, Tohoku University School of Medicine, Miyagi, Japan Dr Shapiro Canada Colin Shapiro, Toronto Western Hospital, Toronto, Canada Dr Siepmann United States Timo Siepmann, Department of Continuing Education, Harvard Medical School, Boston, MA, USA.; Department of Neurology and Institute of Clinical Pharmacology, Carl Gustav Carus University Hospital, Dresden University of Technology, Saxony, Germany Professor Singh Australia Bruce Singh, Professor and Head of Department of Psychiatry, University of Melbourne, Melbourne, Australia Professor Spitzer Germany Manfred Spitzer, Professor of Psychiatry, Psychiatric Hospital at the University of Ulm, Ulm, Germany Professor Trimble United Kingdom Michael R Trimble, Professor, Institute of Neurology, Queen Square, London, UK Prof. Dr. Vieta Spain Eduard Vieta, Professor and Director of Research, Clinical Institute of Neuroscience, Hospital Clinic, University of Barcelona, Spain Professor Wallin Sweden Anders Wallin, Professor, Sahlgrenska University, Mölndal, Sweden Prof. Dr. Yamawaki Japan Shigeto Yamawaki, Professor and Chairman, Hiroshima University, Hiroshima, Japan Dr Yeong Singapore Ng Beng Yeong, Department of Behavioural Medicine, Singapore General Hospital, Singapore Professor Youdim Israel Moussa Youdim, Professor, Eve Topf and US National Parkinson Foundation Centres of Excellence, Haifa, Israel Professor Young Canada Allan Young, Professor, University of British Columbia, Vancouver, Canada Professor Zasler United States Nathan Zasler, Clinical Professor, Department of PM&R, Virginia Commonwealth University, and Clinical Associate Professor, Department of PM&R, University of Virginia, Charlottesville, Virginia, USA Dr Zhu United States Xiongwei Zhu, Department of Pathology, Case Western Reserve University, Cleveland, OH, USA